Form 4: Bioventus Inc. Director Ladone Mary Kay Reports Stock Transaction
SEC Form 4 Filing
Director Ladone Mary Kay reports the vesting and conversion of restricted stock units into Class A Common Stock of Bioventus Inc.
Summary
- On June 7, 2024, Director Ladone Mary Kay vested 30,400 Restricted Stock Units (RSUs) which converted into 30,400 shares of Class A Common Stock.
- Following the transaction, Ladone Mary Kay directly owns 50,674 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the increase in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: Vesting of Restricted Stock Units and conversion to Class A Common Stock |
| 06/11/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.